151 related articles for article (PubMed ID: 28643375)
1. Dried blood spot sampling of nilotinib in patients with chronic myeloid leukaemia: a comparison with venous blood sampling.
Boons CCLM; Chahbouni A; Schimmel AM; Wilhelm AJ; den Hartog YM; Janssen JJWM; Hendrikse NH; Hugtenburg JG; Swart EL
J Pharm Pharmacol; 2017 Oct; 69(10):1265-1274. PubMed ID: 28643375
[TBL] [Abstract][Full Text] [Related]
2. Development of a dried blood spot sampling method towards therapeutic monitoring of radotinib in the treatment of chronic myeloid leukaemia.
Lee J; Jung SY; Choi MY; Park JS; Park SK; Lim SA; Cho KH; Oh SY; Ha J; Kim DW; Lee J
J Clin Pharm Ther; 2020 Oct; 45(5):1006-1013. PubMed ID: 32022312
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of and patients' perspective on nilotinib dried blood spot self-sampling.
Boons CCLM; Timmers L; Janssen JJWM; Swart EL; Hugtenburg JG; Hendrikse NH
Eur J Clin Pharmacol; 2019 Jun; 75(6):825-829. PubMed ID: 30729257
[TBL] [Abstract][Full Text] [Related]
4. Clinical validation of dried blood spot sampling in therapeutic drug monitoring of ciclosporin A in allogeneic stem cell transplant recipients: direct comparison between capillary and venous sampling.
Wilhelm AJ; Klijn A; den Burger JC; Visser OJ; Veldkamp AI; Janssen JJ; Swart EL
Ther Drug Monit; 2013 Feb; 35(1):92-5. PubMed ID: 23296096
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous measurement of imatinib, nilotinib and dasatinib in dried blood spot by ultra high performance liquid chromatography tandem mass spectrometry.
Kralj E; Trontelj J; Pajič T; Kristl A
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 903():150-6. PubMed ID: 22857863
[TBL] [Abstract][Full Text] [Related]
6. Dried blood spot analysis for therapeutic drug monitoring of pazopanib.
de Wit D; den Hartigh J; Gelderblom H; Qian Y; den Hollander M; Verheul H; Guchelaar HJ; van Erp NP
J Clin Pharmacol; 2015 Dec; 55(12):1344-50. PubMed ID: 26032288
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Simple Method for Simultaneously Measuring the Concentrations of BCR-ABL and Bruton Tyrosine Kinase Inhibitors in Dried Blood Spot (DBS): A Pilot Study to Obtain Candidate Conversion Equations for Predicting Plasma Concentration Based on DBS Concentration.
Mukai Y; Yoshida T; Kondo T; Miura J; Inotsume N; Toda T
Ther Drug Monit; 2022 Dec; 44(6):762-770. PubMed ID: 36372934
[TBL] [Abstract][Full Text] [Related]
8. Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Antipsychotics: Drawbacks of Its Clinical Application.
Kloosterboer SM; de Winter BCM; Bahmany S; Al-Hassany L; Dekker A; Dieleman GC; van Gelder T; Dierckx B; Koch BCP
Ther Drug Monit; 2018 Jun; 40(3):344-350. PubMed ID: 29505492
[TBL] [Abstract][Full Text] [Related]
9. Volumetric absorptive microsampling and dried blood spot microsampling vs. conventional venous sampling for tacrolimus trough concentration monitoring.
Veenhof H; Koster RA; Junier LAT; Berger SP; Bakker SJL; Touw DJ
Clin Chem Lab Med; 2020 Sep; 58(10):1687-1695. PubMed ID: 32412437
[TBL] [Abstract][Full Text] [Related]
10. DBS sampling in imatinib therapeutic drug monitoring: from method development to clinical application.
Antunes MV; Raymundo S; Wagner SC; Mattevi VS; Vieira N; Leite R; Reginato F; Capra MZ; Fogliatto L; Linden R
Bioanalysis; 2015; 7(16):2105-17. PubMed ID: 26327189
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of dried blood spot sampling for pharmacokinetic research and therapeutic drug monitoring of anti-tuberculosis drugs in children.
Martial LC; Kerkhoff J; Martinez N; Rodríguez M; Coronel R; Molinas G; Roman M; Gomez R; Aguirre S; Jongedijk E; Huisman J; Touw DJ; Pérez D; Chaparro G; Gonzalez F; Aarnoutse RE; Alffenaar JW; Magis-Escurra C
Int J Antimicrob Agents; 2018 Jul; 52(1):109-113. PubMed ID: 29751121
[TBL] [Abstract][Full Text] [Related]
12. Use of total and unbound imatinib and metabolite LC-MS/MS assay to understand individual responses in CML and GIST patients.
Streit F; Binder L; Hafke A; Brandhorst G; Braulke F; Haase D; Armbrust T; Cameron S; Ramadori G; Oellerich M; Walson P
Ther Drug Monit; 2011 Oct; 33(5):632-43. PubMed ID: 21912334
[TBL] [Abstract][Full Text] [Related]
13. Assessment of a dried blood spot C-reactive protein method to identify disease flares in rheumatoid arthritis patients.
D'Cruz LG; McEleney KG; Cochrane C; Tan KBC; Shukla P; Gardiner PV; Small D; Zhang SD; Gibson DS
Sci Rep; 2020 Dec; 10(1):21089. PubMed ID: 33273485
[TBL] [Abstract][Full Text] [Related]
14. Validation of Dried Blood Spot Cards to Determine Apple Phenolic Metabolites in Human Blood and Plasma After an Acute Intake of Red-Fleshed Apple Snack.
Yuste S; Macià A; Ludwig IA; Romero MP; Fernández-Castillejo S; Catalán Ú; Motilva MJ; Rubió L
Mol Nutr Food Res; 2018 Dec; 62(23):e1800623. PubMed ID: 30328671
[TBL] [Abstract][Full Text] [Related]
15. Study protocol of the RAND-study: a multicenter, prospective cohort study investigating response and adherence to nilotinib treatment in chronic myeloid leukemia.
Boons CC; Swart EL; Timmers L; van de Ven PM; Janssen JJ; Hugtenburg JG
BMC Cancer; 2014 Apr; 14():247. PubMed ID: 24712728
[TBL] [Abstract][Full Text] [Related]
16. Comparing Dried Blood Spots and Plasma Concentrations for Busulfan Therapeutic Drug Monitoring in Children.
Dilo A; Daali Y; Desmeules J; Chalandon Y; Uppugunduri CRS; Ansari M
Ther Drug Monit; 2020 Feb; 42(1):111-117. PubMed ID: 31348116
[TBL] [Abstract][Full Text] [Related]
17. Dried Blood Spot Sampling for Tacrolimus and Mycophenolic Acid in Children: Analytical and Clinical Validation.
Martial LC; Hoogtanders KEJ; Schreuder MF; Cornelissen EA; van der Heijden J; Joore MA; Van Maarseveen EM; Burger DM; Croes S; Brüggemann RJM; Aarnoutse RE
Ther Drug Monit; 2017 Aug; 39(4):412-421. PubMed ID: 28700522
[TBL] [Abstract][Full Text] [Related]
18. Effects of proprotein convertase subtilisin/kexin type 9 and nilotinib plasma concentrations on nilotinib-induced hypercholesterolaemia in patients with chronic myeloid leukaemia.
Abumiya M; Akamine Y; Sato S; Takahashi S; Yoshioka T; Kameoka Y; Takahashi N; Miura M
J Clin Pharm Ther; 2021 Apr; 46(2):382-387. PubMed ID: 33108009
[TBL] [Abstract][Full Text] [Related]
19. Manual punch versus automated flow-through sample desorption for dried blood spot LC-MS/MS analysis of voriconazole.
Martial LC; van den Hombergh E; Tump C; Halmingh O; Burger DM; van Maarseveen EM; Brüggemann RJ; Aarnoutse RE
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1089():16-23. PubMed ID: 29747155
[TBL] [Abstract][Full Text] [Related]
20. Clinical Validation of a Dried Blood Spot Assay for 8 Antihypertensive Drugs and 4 Active Metabolites.
Peeters LEJ; Feyz L; Hameli E; Zwart T; Bahmany S; Daemen J; van Gelder T; Versmissen J; Koch BCP
Ther Drug Monit; 2020 Jun; 42(3):460-467. PubMed ID: 31593031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
